Xiaofeng W. Huang
No.300 Guangzhou Road
Nanjing, 210000, China
Nanjing, 210000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
DRP1-mediated mitophagy facilitates oral squamous cell carcinoma tumor cell survival under glucose restriction.
Journal: Free radical biology & medicine
Published: November 26, 2025
Tumor Vascular Area Quantification Predicts Survival Outcomes in Oral Squamous Cell Carcinoma.
Journal: Oral diseases
Published: March 18, 2025
Tumor cells-derived CXCL17 is associated with up-regulated neutrophil to monocyte ratio and predicts poor prognosis in oral squamous cell carcinoma.
Journal: Frontiers in oncology
Published: March 10, 2025
Highly Expressed NELFE in Tumor Cells at the Invasive Tumor Front Was a Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: October 26, 2024
Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.
Journal: Cancer immunology, immunotherapy : CII
Published: August 19, 2024
Integrating clinical and genomic landscape analysis of perineural invasion identify ACTA1 as an oncogene for oral squamous cell carcinoma.
Journal: Frontiers in cell and developmental biology
Published: July 03, 2024
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial.
Journal: BMC cancer
Published: April 05, 2024
Annexin A5 is a novel prognostic biomarker in oral squamous cell carcinoma.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: December 04, 2023
Stratified endocrine therapy for advanced breast cancer: stratification guided, combination preferred
Journal: Zhonghua yi xue za zhi
Published: September 07, 2023
Last Updated: 09/26/2026